Latest Biofortuna news
Welsh Government Ministers visit Biofortuna to celebrate innovation and skills development
Welsh Government ministers Jack Sergeant MS (fourth from left) and Ken Skates (third from right) pictured with members of the Biofortuna team during ...
Biofortuna is ISO 14001 compliant
We are delighted to announce that we are ISO 14001:2015 compliant! This internationally recognised standard for environmental management systems ...
Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day
Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day. Biofortuna Limited (Deeside, UK), the ...
Back-to-back Bionow nominations acknowledge international growth
We are delighted to share the news that hot on the heels of our 2023 Technical Service Award win, we have again been shortlisted for the 2024 Bionow ...
Lyophilization
...
Biofortuna Recognised as a Leading Developer of Lyo Beads in Rapidly Growing $380M Market
The rapidly growing Lyo beads market The global Lyophilised Reagent Beads market was valued at USD 188 Million in 2023 and is anticipated to ...
Biofortuna completes acquisition of biological sample storage experts Cryoniss
Deeside, Wales 9, May 2024: Biofortuna Limited, the specialist laboratory services and CDMO, has completed the acquisition of Cryoniss Ltd, ...
Continued growth drives sales team expansion
We would like to extend a big Biofortuna welcome to Corinne Niger and Sarah Sadler as they become the latest additions to our European sales team. ...
Bionow nomination recognises technical expertise
We are delighted to share the news that our custom lyo bead Development and Manufacturing service has been shortlisted for the 2023 Bionow awards in ...
Previous news & articles
Bionow nomination recognises technical expertise
We are delighted to share the news that our custom lyo bead Development and Manufacturing service has been shortlisted for the 2023 Bionow awards in ...
Biofortuna in 2023
2023 has been a year of incredible growth for our business Over the last twelve months, we have continued to develop long-term partnerships with some ...
Biofortuna in 2022
2022 has been a remarkable year for our organisation. We have formed unique partnerships with some of the most innovative healthcare and life ...
Welcome to the team Megan, Ish and Georgina
Megan, Ish and Georgina are the latest cohort of Laboratory scientists to join us as we continue on our strategic growth journey that will see ...
Biofortuna closes £1.6M funding round
Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has raised £1.6M in its ...
Biofortuna expands its immunoassay development and manufacturing services
Biofortuna is expanding its IVD service portfolio to provide a greater focus on immunoassay design, development and manufacture. The company has made ...
Biofortuna FDA Inspection Completed Successfully
Biofortuna have successfully completed an FDA site inspection to retain their FDA registered manufacturing site status. The inspection was carried ...
Record year for Biofortuna Contract Services division
Biofortuna Ltd is pleased to announce a record year of growth for its IVD Contract Services division. This growth has been driven by the expansion of ...
Biofortuna Ltd closes a £1.5m funding round
Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze-dried diagnostics and contract services, announces ...
